Streptococcus pneumoniae News and Research

RSS
Streptococcus pneumoniae, or Pneumococcus, is a very common bacterial infection in both industrialized and developing countries. In particular, young children and the elderly represent high-risk populations of developing pneumococcal infections. According to the WHO, the bacterium kills up to one million children under the age of five years each year worldwide. It accounts for many Bacterial Meningitis cases in adults and it is the most common cause of Bacteraemia, Pneumonia, Meningitis and Otitis media in young children.
Discovery on immune system paves way to new vaccine against pneumococcal disease

Discovery on immune system paves way to new vaccine against pneumococcal disease

Scientists recommend research on bacterial vaccine to prevent influenza

Scientists recommend research on bacterial vaccine to prevent influenza

FDA approves Teflaro for treatment of community-acquired bacterial pneumonia

FDA approves Teflaro for treatment of community-acquired bacterial pneumonia

H1N1 linked to increased rate of empyema in children

H1N1 linked to increased rate of empyema in children

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Scientists to monitor effectiveness of Streptococcus vaccine

Scientists to monitor effectiveness of Streptococcus vaccine

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Forest Laboratories' ceftaroline fosamil receives FDA Advisory Committee approval for CABP and cSSSI

Forest Laboratories' ceftaroline fosamil receives FDA Advisory Committee approval for CABP and cSSSI

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

Physician recommends vaccination for Meningitis before children start school

Physician recommends vaccination for Meningitis before children start school

Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study

Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study

Australian scientists uncover the secrets behind one of nature’s most extraordinary biological machines

Australian scientists uncover the secrets behind one of nature’s most extraordinary biological machines

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

Global drug distribution programs one factor in hastening drug resistance, report says

Global drug distribution programs one factor in hastening drug resistance, report says

Silver nanoparticles effective at killing all kinds of bacteria

Silver nanoparticles effective at killing all kinds of bacteria

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis

FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis

BUSM professor receives Individual Biomedical Research Award

BUSM professor receives Individual Biomedical Research Award

Preclinical study of DAS181 for treatment and prevention of ILI published

Preclinical study of DAS181 for treatment and prevention of ILI published

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.